Bladder, Ureter, and Urinary Symptoms You Didn’t Expect

Urinary symptoms can be some of the most confusing parts of endometriosis and adenomyosis. Maybe you’ve been treated for “recurrent UTIs” with negative cultures. Maybe you have painful urination only around your period. Or maybe you have no urinary symptoms at all—yet imaging suddenly shows swelling of a kidney.

This is where urinary tract endometriosis comes in: endometriosis affecting the bladder and/or ureters (the tubes that drain urine from kidneys to the bladder). Drawing on evidence from multiple recent surgical series, symptom studies, and clinical case reports, this article walks through what urinary involvement can look like, how it’s evaluated, and why a multidisciplinary team matters.

What counts as “urinary tract endometriosis”?

Urinary tract endometriosis can involve:

• Bladder endometriosis (lesions in the bladder wall)
• Ureteral endometriosis (lesions around or involving the ureter, sometimes causing narrowing/obstruction)

In a large expert-center surgical cohort of people treated for deep endometriosis, about 1 in 10 had urinary tract lesions when strict criteria were applied. Importantly, most urinary tract disease involved the ureter, not just the bladder—highlighting why urinary endometriosis isn’t only about bladder symptoms.

Symptoms: why urinary tract endometriosis doesn’t always feel “urinary”

Bladder endometriosis can mimic UTI symptoms

Many patients expect bladder endometriosis to cause obvious bleeding in urine, but that’s not the most common pattern. In a reference-center series of bladder endometriosis, painful urination (dysuria) was relatively common, while urgency and visible blood in urine were much less frequent. In other words: bladder involvement often shows up as pain, pressure, or burning—especially cyclically—rather than dramatic hematuria.

Smaller surgical outcome data echo that symptom pattern: in one laparoscopic cohort, patients with bladder endometriosis who returned for follow-up commonly reported dysuria at baseline and often improved after surgery.

Ureteral endometriosis can be silent—until it isn’t

Ureteral disease is the one clinicians worry about because it can cause hydronephrosis (back-up of urine into the kidney) and threaten kidney function. The difficult part: it may cause few or no symptoms. In the expert-center urinary tract cohort, some people required surgery because hydronephrosis was found—even though they weren’t necessarily presenting with classic urinary complaints.

If you take one practical message from this post, let it be this: lack of urinary symptoms does not reliably rule out ureter involvement in deep endometriosis.

Cyclical bleeding is a red flag—even if it’s rare

Visible blood in urine that flares with the menstrual cycle (cyclical hematuria) is uncommon, but it’s a high-signal symptom when it appears. A recent case report illustrated this vividly: a patient had cyclical hematuria from a bladder lesion, confirmed by cystoscopy and biopsy. She also had cyclical bleeding from the belly button (umbilical endometriosis), a reminder that endometriosis can show up in unexpected places—and that cyclical patterns deserve to be taken seriously even when initial exams or ultrasounds are normal.

“Is this endometriosis—or bladder pain syndrome?” Why symptoms overlap

Not all bladder symptoms in people with endometriosis come from endometriosis lesions inside the bladder. A 2026 study using a non-invasive bladder filling/sensitivity paradigm found that people with chronic pelvic pain and bladder symptoms tended to report more pain during bladder filling than controls, but measures like urgency didn’t separate groups as clearly. Interestingly, bladder sensitivity profiles didn’t line up neatly with diagnostic labels (endometriosis-associated pain vs bladder pain syndrome).

One especially patient-relevant point from that work: among participants categorized as having endometriosis-associated pain plus bladder symptoms, the authors reported no visible bladder endometriosis lesions in that subgroup. That supports what many patients live: you can have very real bladder symptoms due to bladder sensitization, pelvic nerve cross-talk, or overlapping pain conditions—even without a bladder lesion that needs to be cut out.

Another notable finding: bladder-filling pain correlated with GI symptom severity, reinforcing the “whole pelvis” reality—bowel and bladder symptoms often travel together.

How is urinary tract endometriosis evaluated?

1) Start with a symptom timeline (especially cyclicity)

Because urinary symptoms can be misleading, a careful history matters:

• Do symptoms flare before/during periods?
• Is pain tied to bladder filling or urination?
• Any episodes of visible blood in urine, especially cyclical?
• Any one-sided flank pain, nausea, or recurrent “kidney infections”?

2) Imaging is helpful—but a negative scan doesn’t always end the story

Expert-center data emphasize a frustrating truth: physical exam and MRI can be quite specific (when they show something, it may be meaningful) but may have limited sensitivity—so urinary involvement can still exist even if imaging looks reassuring.

That’s one reason many referral centers use systematic imaging workups when deep endometriosis is suspected, particularly to assess the ureters and check for hydronephrosis.

3) Cystoscopy + biopsy may be needed for suspected bladder lesions

For bladder endometriosis, cystoscopy can directly visualize a lesion and allow biopsy confirmation. In the case report with cyclical hematuria, cystoscopy revealed a polyp-like bladder lesion and histology confirmed endometriosis—illustrating how targeted testing can end years of uncertainty when symptoms and imaging don’t match.

4) Don’t forget kidney/ureter evaluation

If ureter involvement is suspected (or if deep endometriosis is extensive), clinicians may focus on:

• Signs of ureter narrowing
• Hydroureter/hydronephrosis
• Kidney function monitoring when obstruction is present

Treatment options: when hormones may help vs when surgery is urgent

Hormonal suppression: often a first-line for symptom control (when safe)

Hormonal therapy (such as progestins) can reduce bleeding and inflammation and may improve urinary symptoms in some patients. The bladder + umbilical endometriosis case report described symptom resolution over short follow-up on progestin therapy—useful as a proof-of-possibility, though not a guarantee.

Hormonal treatment tends to make most sense when:

• Symptoms are manageable
• There’s no evidence of ureter obstruction or kidney threat
• The goal is symptom control rather than immediate lesion removal

Surgery: varies widely depending on location and depth

Urinary tract endometriosis surgery isn’t one procedure—it’s a menu of operations chosen based on anatomy and risk.

Bladder surgery can range from “shaving” to full-thickness resection

In a reference-center bladder endometriosis series, surgeons used different techniques:

• Shaving (more superficial disease; bladder not fully opened)
• Mucosal skinning
• Full-thickness resection (when infiltration is deeper)

Full-thickness infiltration was common enough to matter (over a third of patients in that cohort) and was linked to larger lesions. The practical implication: the “right” surgery depends on how deep and where the lesion is—not just how bad symptoms feel.

A smaller Polish surgical cohort also found that laparoscopic surgery was associated with improvement in key symptoms (especially dysuria in bladder endometriosis), though some symptoms did not show clear statistical improvement—likely reflecting small numbers and the reality of multi-site disease.

Ureter surgery can be even more complex—and may be protective of kidney function

In the large urinary tract endometriosis surgical cohort, most cases involved the ureter and many required extensive ureterolysis (freeing the ureter from endometriosis/fibrosis). A subset required ureteral resection with reimplantation into the bladder (ureteroneocystostomy), which is a major reconstructive step.

Why so aggressive sometimes? Because the ureter is a narrow tube: compression or scarring can silently block urine flow and damage the kidney.

Advanced surgical techniques: tools to reduce risk, not eliminate it

A 2026 surgical case report described using indocyanine green (ICG) with near-infrared fluorescence during robotic surgery to help the team visualize a distorted ureter while performing ureterolysis. This kind of technique aims to make surgery safer in difficult anatomy—but it’s still early evidence (a single case), and it doesn’t replace the core need for an experienced, multidisciplinary team.

What to expect after surgery: recovery and complication realities

Patients deserve honest counseling here: urinary tract endometriosis surgery can be highly effective—but it can also carry meaningful risks.

Bladder surgery recovery often includes a catheter

In the reference-center bladder endometriosis cohort, postoperative bladder catheter duration averaged around 10 days overall and was longer when lesions involved the trigone (the sensitive area near the ureter openings) and with more invasive techniques (resection/skinning vs shaving). Hospital stay averaged about 6 days in that cohort—useful for planning time off, childcare help, and expectations.

Complications happen—and rates depend on complexity and definitions

Across studies, complication rates vary widely, reflecting differences in:

• How severe disease was
• Whether ureter and bowel were operated on at the same time
• How complications were counted

In the large urinary tract endometriosis cohort (deep disease managed surgically in an expert center), complications were common, and a notable minority required surgical reintervention. Postoperative voiding dysfunction requiring self-catheterization occurred in a significant subset, occasionally lasting beyond a month. This doesn’t mean surgery is a bad choice—many patients improve—but it does mean “minimally invasive” doesn’t equal “minor.”

On the other hand, the bladder-focused reference-center series reported a lower overall postoperative complication rate (about 10%), and found higher risk with factors that intuitively increase complexity: larger lesions, trigone involvement, full-thickness disease, more organs opened, and prior surgery.

Symptom improvement is common, but recurrence can occur

Surgical follow-up data suggest many patients reduce pain medication needs quickly after urinary tract surgery, and bladder symptoms like dysuria often improve after laparoscopic treatment. Yet recurrence or symptom return still happens for some—one cohort reported dysuria returning in a subset of bladder endometriosis patients around two years later on average. This is why long-term follow-up and a plan for medical management after surgery can matter.

Why multidisciplinary care matters (and when to ask for referral)

Across the surgical literature, one theme keeps repeating: urinary tract endometriosis rarely exists in isolation. In the bladder reference-center series, almost all patients had deep endometriosis elsewhere—bowel, uterus (including adenomyosis/endometriosis patterns), and sometimes ureters. That has real-world consequences:

• You may need gynecology + urology (and sometimes colorectal surgery) in the same plan.
• Removing a bladder lesion without addressing adjacent deep disease may leave symptoms behind.
• Protecting the ureter during pelvic surgery is critical—some cohorts even report conversion to open surgery due to ureter injury in challenging cases.

If you have suspected urinary tract involvement, it’s reasonable to ask whether your case should be evaluated in a dedicated endometriosis referral center with multidisciplinary imaging and surgical planning.

Practical takeaways: what to ask your doctor

• Could my urinary symptoms be from bladder endometriosis, ureter involvement, or bladder sensitization (with no bladder lesion)?
• Do I need imaging specifically looking at the ureters and kidneys (to rule out hydronephrosis)?
• If a bladder lesion is suspected, would cystoscopy and biopsy help confirm it?
• If surgery is on the table: what technique is expected (shaving vs full-thickness resection; ureterolysis vs reimplantation), and what does that mean for catheter time, recovery, and complication risk?
• Will my surgery be planned with a multidisciplinary team (gynecology + urology ± colorectal), and how often does this team manage urinary tract disease?

What we still don’t know (and why individual experiences vary)

Even with improving research, there are gaps that affect patients’ decision-making:

• Many studies are from expert centers and may not reflect outcomes everywhere.
• Symptom improvement is often reported, but long-term outcomes like quality of life, sexual function, fertility, and durable urinary function are inconsistently measured.
• Urinary symptoms don’t map neatly onto anatomy: people can have major bladder symptoms without bladder lesions, and ureter disease can be silent.
• Newer surgical tools (like fluorescence-guided ureter visualization) are promising but need larger comparative data to show whether they reduce injuries or long-term complications.

The most realistic, patient-centered conclusion from the combined evidence is this: urinary symptoms in endometriosis are real, common, and not always straightforward. Getting the right answer often requires looking beyond “UTI vs endo,” evaluating the whole pelvis (and urinary tract), and matching treatment to what’s actually happening—symptoms, anatomy, and risk to organs like the kidneys.